Utah Medical Products/$UTMD
1D1W1MYTD1Y5YMAX
Capital at risk
About Utah Medical Products
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
- Ticker
- $UTMD
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 146
- Headquarters
- Midvale, United States
- Website
- www.utahmed.com
UTMD Metrics
BasicAdvanced
$236M
22.56
$3.28
0.36
$1.24
1.67%
Price and volume
Market cap
$236M
Beta
0.36
52-week high
$75.75
52-week low
$53.66
Average daily volume
34K
Dividend rate
$1.24
Financial strength
Current ratio
48.618
Quick ratio
44.006
Long term debt to equity
0.002
Total debt to equity
0.002
Dividend payout ratio (TTM)
37.58%
Profitability
EBITDA (TTM)
14.816
Gross margin (TTM)
57.90%
Net profit margin (TTM)
29.04%
Operating margin (TTM)
33.15%
Effective tax rate (TTM)
18.60%
Revenue per employee (TTM)
$250,000
Management effectiveness
Return on assets (TTM)
6.10%
Return on equity (TTM)
8.75%
Valuation
Price to earnings (TTM)
22.558
Price to revenue (TTM)
6.549
Price to book
1.93
Price to tangible book (TTM)
2.19
Price to free cash flow (TTM)
20.658
Free cash flow yield (TTM)
4.84%
Free cash flow per share (TTM)
3.585
Dividend yield (TTM)
1.67%
Forward dividend yield
1.67%
Growth
Revenue change (TTM)
-7.00%
Earnings per share change (TTM)
-12.33%
3-year revenue growth (CAGR)
-11.40%
10-year revenue growth (CAGR)
-1.06%
3-year earnings per share growth (CAGR)
-11.57%
10-year earnings per share growth (CAGR)
-0.28%
3-year dividend per share growth (CAGR)
1.67%
10-year dividend per share growth (CAGR)
-2.21%
UTMD Financial Performance
Revenues and expenses
Upcoming events
UTMD News
AllArticlesVideos
Funds containing UTMD
Fund name | Fund size | $UTMD weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.